NEWS RELEASE - Another 10M in debt.

Never fear, time is near.  Time to find a buyer.  10 B buyout, between 30 and 35 per share after commissions, pay all liabilities including Zenith.  Maybe BP buys Zenith too.

At this time, will take that and run! RVX will never see 100 SP.  Not with current management.  Just mind boggling how a science proved company cannot make it out the door.

Where is BP with 10B?  Believe BP sees a sinking ship, can buy cheap through bankruptcy court.  Just out bid the other BP.  We get lucky with 4 per share.  That is just hoping!

How do I get 10 B, with BTD, a safe compound and 30 other compounds using epigenetics has value to BP, plus the scientists within RVX.  That is the value.

Sour grapes, NO.  With meeting soon to be, best to ask about financing, how much dilution do we expect with 30 cents a share, over selling company now and watching ABL fly with new management. Will be proud to know we were part of a new drug.

We read the science, we bought, we waited.  Where is the finish line?  Still waiting.

Should be a mad race when employees pay checks bounce.  sidebar - just disappointed -